PT. Prodia Stem Cell Indonesia
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS8
PHASE 3 / 2-31
RECRUITING3
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO100%
Delay Index: of 5 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +51.0 months). See all sponsors →
Open PT. Prodia Stem Cell Indonesia on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Auto-DC (Autologous Dendritic Cell as Adjuvant Therapy) NCT05261750 |
P1/2 | Active, not recruiting | Nasopharyngeal Cancer | 15 | 2026-02-28 (+47 mo) |
| Conditioned Medium NCT05008588 |
P1/2 | Active, not recruiting | Ischemic Stroke | 15 | 2026-03 (+51 mo) |
| Secretome NCT07429253 |
P1/2 | Recruiting | Androgenetic Alopecia | 40 | 2026-06-30 |
| Umbilical Cord Mesenchymal Stem Cells NCT04314687 |
P1/2 | Active, not recruiting | Cerebral Palsy | 78 | 2026-07 (+72 mo) |
| Control (NaCl 0.9%) NCT07439848 |
P1/2 | Recruiting | Acute Respiratory Distress Syndrome | 15 | 2026-12 |
| Allogeneic Umbilical Cord Mesenchymal Stem Cell NCT04357600 |
P1/2 | Enrolling by invitation | Liver Cirrhoses | 12 | 2027-06-20 (+78 mo) |
| Umbilical Cord Mesenchymal Stem Cells NCT07396155 |
P1/2 | Recruiting | Diabetic Nephropathy Type 2 | 10 | 2027-07 |
| 1.5 x 10^6 UC-MSC + CM NCT05909488 |
P2/3 | Not yet recruiting | Retinitis Pigmentosa | 30 | 2027-07 (+19 mo) |